MERLO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 27.118
AS - Asia 17.960
EU - Europa 17.124
SA - Sud America 2.553
AF - Africa 570
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 31
Totale 65.408
Nazione #
US - Stati Uniti d'America 26.542
SG - Singapore 6.927
IT - Italia 5.140
CN - Cina 4.192
PL - Polonia 2.244
VN - Vietnam 1.941
BR - Brasile 1.920
HK - Hong Kong 1.682
DE - Germania 1.614
SE - Svezia 1.511
FR - Francia 1.141
KR - Corea 1.094
GB - Regno Unito 886
NL - Olanda 795
FI - Finlandia 729
RU - Federazione Russa 716
UA - Ucraina 544
IN - India 439
BG - Bulgaria 392
IE - Irlanda 354
TR - Turchia 304
CA - Canada 280
AR - Argentina 211
BD - Bangladesh 201
JP - Giappone 200
CH - Svizzera 191
AT - Austria 181
MX - Messico 181
ES - Italia 178
MA - Marocco 147
ZA - Sudafrica 134
ID - Indonesia 125
IQ - Iraq 112
EC - Ecuador 88
BE - Belgio 78
CL - Cile 77
CO - Colombia 75
PK - Pakistan 75
SA - Arabia Saudita 69
EG - Egitto 64
RO - Romania 62
VE - Venezuela 62
PH - Filippine 60
CZ - Repubblica Ceca 53
IR - Iran 53
GR - Grecia 52
AE - Emirati Arabi Uniti 46
PE - Perù 44
AU - Australia 41
UZ - Uzbekistan 41
JO - Giordania 40
PT - Portogallo 38
PY - Paraguay 38
SN - Senegal 37
KE - Kenya 36
LT - Lituania 36
KZ - Kazakistan 33
DZ - Algeria 32
TH - Thailandia 32
MY - Malesia 31
TW - Taiwan 31
AZ - Azerbaigian 30
IL - Israele 30
TN - Tunisia 26
EU - Europa 25
RS - Serbia 25
NP - Nepal 24
UY - Uruguay 23
OM - Oman 20
AL - Albania 19
LV - Lettonia 19
PA - Panama 18
KG - Kirghizistan 17
CR - Costa Rica 16
SK - Slovacchia (Repubblica Slovacca) 16
HU - Ungheria 15
DO - Repubblica Dominicana 14
BO - Bolivia 13
BY - Bielorussia 13
DK - Danimarca 13
ET - Etiopia 13
SI - Slovenia 12
CY - Cipro 11
HR - Croazia 11
JM - Giamaica 11
KW - Kuwait 11
LK - Sri Lanka 11
NG - Nigeria 11
HN - Honduras 10
MD - Moldavia 10
TG - Togo 10
GE - Georgia 9
NO - Norvegia 9
AO - Angola 8
LA - Repubblica Popolare Democratica del Laos 8
LB - Libano 8
NZ - Nuova Zelanda 8
PS - Palestinian Territory 8
TT - Trinidad e Tobago 8
LU - Lussemburgo 7
Totale 65.242
Città #
Singapore 4.163
Ashburn 3.397
Fairfield 2.069
Chandler 1.800
Warsaw 1.797
San Jose 1.719
Hong Kong 1.609
Woodbridge 1.501
Ann Arbor 1.108
Houston 1.085
Seoul 1.066
Hefei 1.043
Beijing 960
Seattle 900
Trieste 893
Wilmington 876
Chicago 726
Cambridge 718
Boardman 629
Dallas 628
Ho Chi Minh City 600
Los Angeles 549
Jacksonville 544
Princeton 460
Hanoi 433
Milan 424
Council Bluffs 400
Helsinki 400
Lauterbourg 399
Sofia 382
London 365
Zgierz 363
Munich 361
Dublin 342
Columbus 337
Santa Clara 329
Frankfurt am Main 282
Rome 276
Moscow 263
New York 261
The Dalles 252
São Paulo 200
Izmir 188
Buffalo 183
Amsterdam 178
Dearborn 162
Orem 134
Tokyo 130
San Diego 128
Düsseldorf 121
Naples 118
Bern 115
Salt Lake City 108
Da Nang 106
Casablanca 105
Lappeenranta 104
Nuremberg 104
Vienna 104
Grafing 103
Montreal 100
Atlanta 93
Denver 92
Phoenix 86
Turku 86
Redondo Beach 85
Chennai 83
Shanghai 83
Guangzhou 81
Washington 81
Bologna 77
Venice 77
Toronto 76
Brooklyn 73
Haiphong 70
Bremen 69
Brussels 68
Dong Ket 68
Stockholm 64
Turin 64
Johannesburg 63
Poplar 59
Venezia 59
Florence 56
Des Moines 55
Boston 53
Jinan 53
Redwood City 53
Rio de Janeiro 53
Mexico City 52
Pune 52
Tampa 52
Udine 52
Verona 52
Elk Grove Village 51
Manchester 51
San Francisco 50
Mumbai 49
Roubaix 47
Wroclaw 47
Falls Church 46
Totale 41.781
Nome #
Does Ectopic Beats Bring More Discriminatory Information to Diagnose Ischemic Heart Disease? 464
Arresto cardiaco extraospedaliero: le competenze degli studenti dell’Università degli Studi di Trieste sulle manovre rianimatorie e l’utilizzo del defibrillatore automatico esterno 449
Natural History of Dilated Cardiomyopathy in Children 426
Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias 420
Role of Titin Missense Variants in Dilated Cardiomyopathy 416
Miocardite, cardiomiopatia infiammatoria e perimiocardite: possiamo fare ordine? 403
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 402
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 396
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures 387
Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist? 384
Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives 359
I dieci punti che il cardiologo deve conoscere su scintigrafia miocardica con traccianti ossei, amiloidosi e cuore 358
Conflicting gender-related differences in the natural history of patients with idiopathic dilated cardiomyopathy 345
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy 335
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 327
Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History 314
Documento di consenso Società Italiana di Cardiologia- Società Italiana di Nefrologia: Ruolo dell’asse cardio-renale nella prevenzione e trattamento delle patologie cardiovascolari – Parte II: Dalle strategie di prevenzione al trattamento del paziente con coinvolgimento cardio-renale 312
Impact of Aging on Heart Rate Variability Properties of Healthy Subjects 309
La cardiomiopatia dilatativa come malattia dinamica: storia naturale, rimodellamento inverso e stratificazione prognostica 307
Deleterious impact of mild anemia on survival of young adult patients (age 45 ± 14 years) with idiopathic dilated cardiomyopathy: data from the Trieste Cardiomyopathies Registry. 295
Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment? 289
High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients 286
Infiltrative/storage cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 280
Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathy 280
Contemporary etiology and prognosis of dilated non-ischemic cardiomyopathy 279
Cardiac amyloidosis: a changing epidemiology with open challenges 278
Com'è cambiata la storia naturale della cardiomiopatia dilatativa? 275
Dieci quesiti in tema di miocardite eosinofila [Ten questions about eosinophilic myocarditis] 275
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 271
Prognostic impact of short-term changes of E/E' ratio and left atrial size in dilated cardiomyopathy 270
null 266
Other cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 264
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization 264
Historical Terminology, Classifications, and Present Definition of DCM. 262
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 261
Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy 260
Interchangeability of B type natriuretic peptide measurements in lithium heparin and K2EDTA: agreement between matrices and differences in diagnostic accuracy. 257
Influence of Aging on Short- and Long-term Heart Rate Variability in Patients with Heart Failure 257
Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection 256
Outcome of the multidimensional prognostic index in ultra-octogenarian patients hospitalized for cardiovascular diseases 255
Acute Hemodynamic Response to Cardiac Resynchronization in Dilated Cardiomyopathy: Effect on Late Mitral Regurgitation 255
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 252
Chapter 6: Clinical Presentation, Spectrum of Disease, and Natural History 251
HRV analysis in CHF patients with different etiologies by means of spectral and nonlinear indexes 250
Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy 249
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 248
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy 248
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy 246
Chapter 12: Prognostic Stratification and Importance of Follow-Up 243
Emergency Surgery and Cardiac Devices 242
Treatment of Functional Mitral Regurgitation in Heart Failure 242
Genetics of Dilated Cardiomyopathy: Clinical Implications 242
Clinical characterization and natural history of chemotherapy-induced dilated cardiomyopathy 241
Cardiovascular aging: the unveiled enigma from bench to bedside 240
Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure 239
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach 239
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 238
Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry 238
Myocarditis in Clinical Practice 236
ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis 235
Myocarditis evolving in cardiomyopathy: When genetics and offending causes work together 234
Evolving concepts in dilated cardiomyopathy 234
Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. 230
Idiopathic dilated cardiomyopathy and persistent viral infection: Lack of association in a controlled study using a quantitative assay. 230
Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy 230
Early right ventricular response to cardiac resynchronization therapy: Impact on clinical outcomes 229
ECG in dilated cardiomyopathy: Specific findings and long-term prognostic significance 228
Arrhythmogenic right ventricular cardiomyopathy: Arrhythmogenic right ventricular cardiomyopathy: Clinical assessment and differential diagnosis 228
Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy 224
Predictors for Restoration of Normal Left Ventricular Function in Response to Cardiac Resynchronization Therapy Measured at Time of Implantation. 224
Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. 224
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 223
Left Atrial Reverse Remodeling in Dilated Cardiomyopathy 222
Chapter 14: Unresolved Issues and Future Perspectives 222
Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors 221
Echocardiographic evaluation of systolic and mean pulmonary artery pressure in the follow-up of patients with pulmonary hypertension. 218
Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. 218
Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle 218
Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment. 216
Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathyhttps://arts.units.it/submit?resume=115962# 216
ICD replacement in patients with intermediate left ventricular dysfunction under optimal medical treatment 216
Chapter 3: Pathophysiology 216
Apoptosis in patients with acute myocarditis. 215
Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction 215
[Sudden cardiac death in patients with left ventricular dysfunction from ischemic heart disease: role of the implantable defibrillator. Evidence, guidelines and good clinical judgment]. 214
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers 213
Clinical Echocardiography and Other Imaging Techniques in Cardiomyopathies 212
The Prognostic Impact of the Evolution of RV Function in Idiopathic DCM 212
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy 211
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction 211
Dilated Cardiomyopathy. From Genetics to Clinical Management 210
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 210
DEFINITION, CLASSIFICATION, EPIDEMIOLOGY, AND CLINICAL RELEVANCE OF CARDIOMYOPATHIES. 209
Clinical management of dilated cardiomyopathy: Current knowledge and future perspectives 209
Formation of the inflammasome in acute myocarditis. 207
Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF 206
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 205
Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry 205
Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis 203
Role of the Electrocardiogram in Differentiating Genetically Determined Dilated Cardiomyopathy from Athlete's Heart 200
Totale 26.355
Categoria #
all - tutte 191.620
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 191.620


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021971 0 0 0 0 0 0 0 0 0 423 183 365
2021/20223.283 127 226 249 252 187 307 153 94 379 336 235 738
2022/20235.556 425 710 545 844 464 872 84 467 589 120 277 159
2023/20244.941 362 263 224 363 434 522 769 722 124 188 531 439
2024/202511.760 327 646 1.084 959 978 940 742 693 1.311 1.589 1.148 1.343
2025/202626.800 3.375 1.774 2.570 2.837 2.390 2.442 3.779 1.155 3.320 3.158 0 0
Totale 67.118